Kim Jae B. 4
4 · Avidity Biosciences, Inc. · Filed Jul 27, 2020
Insider Transaction Report
Form 4
Kim Jae B.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-07-27+375,266→ 375,266 totalExercise: $25.05Exp: 2030-07-26→ Common Stock (375,266 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on July 27, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continuous service to the Registrant on each such vesting date.